Navigation Links
Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients
Date:10/26/2008

Data Analysis of Up to Four Years of Treatment Presented at ICAAC/IDSA 2008 Annual Meeting

WASHINGTON, Oct. 26 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today reported a data analysis showing that vicriviroc, its investigational CCR5 receptor antagonist, demonstrated sustained viral suppression and increased CD4 cell counts and was well tolerated through up to four years of therapy in treatment-experienced HIV-infected patients. Vicriviroc was administered once-daily as a single tablet in combination with an optimized antiretroviral regimen containing a ritonavir-boosted protease inhibitor. These results represent the longest treatment duration and clinical experience reported to date for a CCR5 receptor antagonist.

Vicriviroc, currently in Phase III development, is an extracellular inhibitor of HIV infection designed to prevent the virus from infecting the immune system's CD4 cells by blocking the CCR5 co-receptor. Approximately 50-60 percent of treatment-experienced patients have virus that uses the CCR5 co-receptor.(1)

Researchers presented the data at the joint Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and Infectious Diseases Society of America (IDSA) annual meeting.(2)

The pooled data analysis involved 205 treatment-experienced HIV-infected patients from two vicriviroc Phase II studies who continued on vicriviroc at the completion of 48 weeks of treatment in an open-label extension for each study. Patients received vicriviroc for up to 216 weeks of total treatment duration as part of an optimized antiretroviral regimen.

This analysis showed that vicriviroc was well tolerated overall, with patients developing few complications of HIV disease. Adve
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , HARBIN, China, Nov. 25 /PRNewswire-Asia... Sky One Medical" or "the Company") (Nasdaq: CSKI...any developing and producing,over-the-counter drug...,announced that the Company recently passed the Ch...ceutical and Biological Products ("ICPBP") examina...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Reportli...rt is available in its catalogue: ,, Mammogra..., http://www.reportlinker.com/p0164330/Mammograph..., Rising incidence of breast cancer in industria... factor influencing growth in the mammography mark...
(Date:11/25/2009)..., EAST BRUNSWICK, N.J., Nov. 25 ...er of direct digital Radiography ( ddR ) systems, ...ired by a private Swiss Investor with a long term ...and. The acquisition included all assets and intel...ry. After 25 years of success and growth Swissray ...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8Swissray International Announces New Ownership 2Society of Interventional Radiology offers resources on stroke carotid artery disease 61138 1Society of Interventional Radiology offers resources on stroke carotid artery disease 61138 2Californias ancient kelp forest 10685 1Californias ancient kelp forest 10685 2D A R E Partners with MedSafe to Tackle Teen Prescription and Over the Counter Drug Abuse at Home 61134 1D A R E Partners with MedSafe to Tackle Teen Prescription and Over the Counter Drug Abuse at Home 61134 2D A R E Partners with MedSafe to Tackle Teen Prescription and Over the Counter Drug Abuse at Home 61134 3
...- Mersana, a,cancer therapeutics company, announce...ts lead product candidate, XMT-1001, will,be prese...the,American Association of Cancer Research (AACR)...ll text of the abstracts can be,viewed online at t...//www.aacr.org/">http://www.AACR.org . , The prese...
...- Biogen Idec Inc.,(NASDAQ: BIIB) announced today ...aged Care Pharmacy,s (AMCP) 2007 Annual Meeting sh...ffective therapy in,multiple sclerosis (MS) when c... a comprehensive analysis of medical and pharmacy,...patients treated,with AVONEX, the most prescribed ...
Other Medicine Technology:Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001,at American Association of Cancer Research Annual Meeting 2New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective,Relative to Other Interferon Therapies for Multiple Sclerosis 2New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective,Relative to Other Interferon Therapies for Multiple Sclerosis 3
(Date:11/27/2009)... vehicles may reduce future disease burden, resear... News) -- Encouraging city dwellers to walk and bi...er public health benefits than increased used of l... , The study compared the projected health effe...enarios for London, England, and Delhi, India: bu...
(Date:11/27/2009)...th™ announced today that Spectrum Health (Gr...nterprise orthopedic templating solution and its T... (PRWEB) November 27, 2009 -- Voyant He...Grand Rapids, Michigan) has licensed its TraumaCad... TraumaCad Extend workflow solution, to allow its ...
(Date:11/27/2009)...nteractive anatomy education apps from Modality an...sciences learning opportunities for iPhone and iPo...us) November 27, 2009 -- Modality, Inc. and Lipp... Wolters Kluwer Health, today announced the availa...App Store. Clemente’s Anatomy, Rohen’s...
(Date:11/26/2009)... Americans living with diabetes will nearly double...lion in 2034. Over the same period, spending on di...n to $336 billion, even with no increase in the pr...ersity of Chicago report in the December issue of ...etes covered by Medicare will rise from 8.2 millio...
(Date:11/26/2009)...motional rollercoaster, study finds , , ...fear factor meets the jubilant sports fan. , A ...hose who root for the winning team -- enjoy the gr...tch and victory was in doubt, producing feelings o...hanksgiving weekend as you,re glued to the TV set,...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
... A multi-million dollar gift from one of Rochester...University of Rochester Medical Center,s (URMC) n... comprehensive center for investigating and treati..., , Ernest J. Del Monte , chairman of E.J. Del M...
...te focuses on themes of faith, family and hope , ... the NAMI Advocate Magazine features a cover story... Alliance on Mental Illness (NAMI) had with Presid...t a picnic table in a park in Billings, Montana ta...
...ings of a landmark drug comparison study published...outperformed other medications for high blood pres...om The University of Texas Health Science Center a...blood pressure, which, according to the National H...
...d Research of Advanced Technologies for Early Dise...Baylor Institute for Immunology Research (BIIR) in...nd the Baylor Health Care System, announced today ...- including swine flu (H1N1). The grant will also ...
...tor of the Office on Women,s Health , , WASHINGTO...ivingquilt.org ), a unique web project that colle... lines of the fight against HIV/AIDS, today announ... and Human Services. The milestone comes as the na...
... with common vision problems can find glasses or c...m diseases of the eye that affect the focus of lig...o learn to live with poor vision. , At the Unive...tom contact lenses. , "The lenses we make are mad...
Other Medicine News:Health News:$10 Million Gift to Transform Neuromedicine at URMC 2Health News:$10 Million Gift to Transform Neuromedicine at URMC 3Health News:$10 Million Gift to Transform Neuromedicine at URMC 4Health News:$10 Million Gift to Transform Neuromedicine at URMC 5Health News:NAMI Magazine Cover Features President Obama 2Health News:New research confirms milestone study on blood pressure meds 2Health News:New research confirms milestone study on blood pressure meds 3Health News:Baylor Research Institute Receives Multi-Million Dollar Grant To Develop Flu Vaccine 2Health News:Baylor Research Institute Receives Multi-Million Dollar Grant To Develop Flu Vaccine 3Health News:Southern AIDS Living Quilt Posts 100th Video Patch During National Women's Health Week 2Health News:UH optometrists make custom contact lenses for long-underserved patients 2Health News:UH optometrists make custom contact lenses for long-underserved patients 3Health News:UH optometrists make custom contact lenses for long-underserved patients 4
IDS Rapid SS/u
Versatrek 240
ELP 40
96 PW Microplate Washer
Medicine Products: